W Glenn McCluggage Selected Research

Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor)

3/2019	Sex Cord-stromal Tumors With Steroid Cell Tumor and Fibroma Components: Report of 2 Cases, Including One of Extraovarian Origin.
1/2019	Ovarian Sex Cord-stromal Tumors With Melanin Pigment: Report of a Previously Undescribed Phenomenon.
7/2007	CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Glenn McCluggage Research Topics

Disease

72	Neoplasms (Cancer) 08/2022 - 01/2002
34	Carcinoma (Carcinomatosis) 11/2022 - 05/2004
20	Adenocarcinoma 08/2022 - 01/2002
13	Endometrial Neoplasms (Endometrial Cancer) 07/2022 - 05/2004
9	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
7	Sarcoma (Soft Tissue Sarcoma) 09/2022 - 06/2015
7	Endometrioid Carcinoma 03/2022 - 02/2005
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 05/2010
6	Neoplasm Metastasis (Metastasis) 08/2022 - 03/2010
5	Polyps 09/2021 - 05/2004
5	Sertoli-Leydig Cell Tumor 11/2019 - 04/2007
5	Ovarian Epithelial Carcinoma 01/2018 - 04/2009
4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 11/2022 - 08/2014
4	Hyperplasia 03/2022 - 02/2006
4	Carcinogenesis 01/2022 - 03/2006
4	Adenosarcoma 01/2021 - 01/2002
4	Adenocarcinoma in Situ 09/2020 - 05/2009
4	Fibroma (Fibromatosis) 03/2019 - 07/2007
4	Granulosa Cell Tumor 01/2019 - 02/2005
3	Uterine Neoplasms (Uterine Cancer) 09/2022 - 05/2004
3	Neuroendocrine Carcinoma 07/2022 - 04/2010
3	Disease Progression 01/2022 - 07/2016
3	Teratoma (Teratoid Tumor) 09/2020 - 02/2005
3	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 03/2019 - 07/2007
3	Uterine Cervical Dysplasia 04/2015 - 01/2013
2	Smooth Muscle Tumor 02/2022 - 06/2017
2	Endometrial Stromal Sarcoma 01/2022 - 05/2015
2	Embryonal Rhabdomyosarcoma 01/2021 - 10/2013
2	Small Cell Carcinoma 05/2019 - 11/2016
2	Sertoli Cell Tumor 01/2019 - 07/2007
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 05/2018 - 02/2005
2	Lobular Carcinoma 01/2018 - 11/2010
2	Leiomyosarcoma 06/2017 - 06/2011
2	Leiomyoma (Uterine Fibroids) 06/2017 - 06/2011
2	Myxoma (Myxomas) 07/2010 - 07/2008
2	Carcinoid Tumor (Carcinoid) 01/2009 - 02/2005
1	Ovarian Teratoma 11/2022
1	Vulvar Neoplasms (Vulvar Cancer) 09/2022

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2002
10	Estrogen ReceptorsIBA 09/2022 - 01/2002
10	Calbindin 2IBA 01/2021 - 02/2005
8	Cyclin D1IBA 09/2022 - 05/2015
8	VimentinIBA 10/2015 - 01/2002
7	Progesterone Receptors (Progesterone Receptor)IBA 09/2022 - 03/2012
7	MucinsIBA 01/2021 - 06/2009
7	Biomarkers (Surrogate Marker)IBA 12/2020 - 09/2010
7	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 02/2005
6	Inhibins (Inhibin)IBA 01/2021 - 02/2005
6	Hormones (Hormone)IBA 01/2021 - 10/2009
5	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2017
5	Keratins (Keratin)IBA 01/2009 - 02/2006
4	DesminIBA 09/2022 - 03/2013
4	Biological ProductsIBA 01/2022 - 01/2018
4	MyogeninIBA 09/2021 - 03/2013
4	ChromograninsIBA 09/2020 - 04/2010
4	DNA (Deoxyribonucleic Acid)IBA 03/2019 - 07/2004
3	CateninsIBA 05/2022 - 10/2015
3	Progestins (Progestagens)IBA 03/2022 - 06/2011
3	ChromatinIBA 05/2021 - 11/2016
3	Keratin-7 (Cytokeratin 7)IBA 01/2021 - 04/2007
3	SteroidsIBA 03/2019 - 05/2006
3	Cadherins (E-Cadherin)IBA 01/2019 - 11/2010
3	Estrogens (Estrogen)FDA Link 01/2019 - 03/2013
3	PlatinumIBA 01/2019 - 12/2011
3	Indicators and Reagents (Reagents)IBA 03/2016 - 01/2013
3	Carcinoembryonic AntigenIBA 01/2013 - 01/2002
3	ElementsIBA 01/2013 - 01/2002
2	Sucrose (Saccharose)IBA 07/2022 - 11/2016
2	LigandsIBA 05/2022 - 11/2021
2	Calmodulin-Binding Proteins (Caldesmon)IBA 02/2022 - 05/2004
2	Ribonucleases (Ribonuclease)IBA 09/2021 - 01/2021
2	CAM 5.2 antigenIBA 01/2021 - 02/2013
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	ParaffinIBA 12/2020 - 10/2015
2	Immune Checkpoint InhibitorsIBA 12/2020 - 11/2020
2	AntibodiesIBA 05/2019 - 05/2004
2	beta CateninIBA 02/2019 - 01/2018
2	Melanins (Melanin)IBA 01/2019 - 10/2006
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2018 - 02/2005
2	Hepatocyte Nuclear FactorsIBA 01/2018 - 03/2012
2	Phenobarbital (Luminal)FDA Link 06/2016 - 02/2015
2	Transcription Factors (Transcription Factor)IBA 06/2016 - 01/2009
2	Diethylstilbestrol (Stilbestrol)FDA Link 05/2014 - 03/2012
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 11/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2014 - 06/2007
2	BRCA1 ProteinIBA 01/2013 - 12/2011
2	Pharmaceutical PreparationsIBA 03/2011 - 11/2010
2	Monoclonal AntibodiesIBA 04/2010 - 01/2002

Therapy/Procedure

15	Hysterectomy 09/2022 - 03/2006
9	Drug Therapy (Chemotherapy) 04/2021 - 01/2002
6	Radiotherapy 01/2021 - 01/2018
5	Therapeutics 03/2022 - 02/2011
5	Salpingo-oophorectomy 01/2022 - 08/2014
4	Ovariectomy (Oophorectomy) 01/2022 - 03/2015
4	Lymph Node Excision (Lymph Node Dissection) 09/2021 - 02/2012
3	Neoadjuvant Therapy 12/2018 - 08/2015
2	Salpingectomy 01/2022 - 01/2021
2	Curettage 01/2019 - 03/2006
2	Cystectomy 06/2017 - 03/2015
2	Adjuvant Chemotherapy 07/2016 - 07/2015